Sign in
Active, not recruitingNo phase

HAP/VAP Diagnosis in Critically Ill Septic Patients Using a Multiplex PCR Array

Key facts

Who runs it
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Where
Italy4 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
126 people, planned
Started
3 Apr 2024
Expected to end
1 Dec 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Lower tract respiratory samples
  • Multiplex PCR assay (Film-array Pneumonia Panel Plus)
  • Lower respiratory tract standard culture
  • Blood sample standard culture
Record updated
13 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Suspicion of HAP/VAP (clinical/radiological/laboratory criteria)
  • Availability to perform tracheal aspirates or broncoalveolar lavage within 1 hour from clinical suspicion
  • Life expectancy ≥ 48 hours
  • Signed written informed consent

Who cannot take part

  • Concomitant participating in other interventional trial
  • Pregnancy,
  • Refusal to sign informed consent

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Multicenter, randomized, controlled, open-label trial to assess if semiquantitative multiplex PCR assay, as compared to conventional microbiology, can reduce the percentage of patients without microbiological diagnosis in the first 24 hours from HAP/VAP suspicion, thus allowing early de-escalation.

The 2 groups in the trial

  • Film-array Pneumonia Panel Plus groupTreatment being tested

    Patients with suspected HAP or VAP in which lower tract respiratory samples are analyzed with new multiplex PCR assay (Film-array Pneumonia Panel Plus)

    Treatment: Lower tract respiratory samples, Multiplex PCR assay (Film-array Pneumonia Panel Plus), Lower respiratory tract standard culture, and Blood sample standard culture

  • Standard culture group (control group)Existing treatment, for comparison

    Patients with suspected HAP or VAP in which lower tract respiratory samples are analyzed with standard culture

    Treatment: Lower tract respiratory samples, Lower respiratory tract standard culture, and Blood sample standard culture

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
HAP/VAP Diagnosis in Critically Ill Septic Patients Using a Multiplex PCR Assay: A Multicenter Randomized Open-Label Trial. THE LIGHTNING STUDY
Record updated
13 October 2026